4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000899243-20-019846
Director bought 25,000 shares at $20.00 ($500,000)
- Director acquired 560,446 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murcko Mark Director | 2020-07-20 | Conversion | +281,617 | 718,123 | D | ||
| Murcko Mark Director | 2020-07-20 | Conversion | +278,829 | 996,952 | D | ||
| Murcko Mark Director | 2020-07-20 | Purchase | +25,000 | $20.00 | $500,000 | 1,021,952 | D |
| Derivatives | |||||||
| Murcko Mark Director | 2020-07-20 | Conversion · Series A Convertible Preferred Stock | −1,000,000 | 0 | D | ||
| Murcko Mark Director | 2020-07-20 | Conversion · Series B Convertible Preferred Stock | −990,099 | 0 | D | ||
| Open-market purchases · 25,000 sh · avg $20.00 · $500,000 | |||||||
Loading xslF345X03/doc4.xml…